Trials / Completed
CompletedNCT01070615
Study to Evaluate Long-Term Tolerability and Safety of Oral Prucalopride in Chronic Constipation
A Study to Evaluate the Long-Term Tolerability and Safety of Oral Prucalopride Administered to Patients With Chronic Constipation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 693 (actual)
- Sponsor
- Movetis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Objectives: Evaluation of the clinical long-term safety, tolerability, patient satisfaction, pharmacokinetics and pattern of use of oral prucalopride tablets given in doses up to 4 mg once daily to patients with chronic constipation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prucalopride |
Timeline
- Start date
- 1998-06-01
- Primary completion
- 2000-11-01
- First posted
- 2010-02-18
- Last updated
- 2010-03-02
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01070615. Inclusion in this directory is not an endorsement.